This inventor holds 14 USPTO granted patents and 1 EPO patent. Top assignees: Vtv Therapeutics LLC, Purdue Pharma L.p., High Point Pharmaceuticals, LLC. Active years: 2006-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newtown, PA (US) (2006 - 2011)
- Oak Ridge, NC (US) (2009 - 2020)
- Winston-Salem, NC (US) (2021 - 2023)
Company Filing History:
7 out of 54 
3 out of 547 
2 out of 50 Years Active: 2006-2023
Title: Innovations and Contributions of Inventor Samuel F. Victory
Introduction
Samuel F. Victory, based in Newtown, PA, is a prominent inventor known for his significant contributions to pharmaceutical innovations. With 14 patents to his name, Victory has made notable advancements in the field of medicinal chemistry, particularly in the development of new compounds that have potential therapeutic uses.
Latest Patents
Among his latest patents, Victory has developed substituted fused imidazole derivatives, which include pharmaceutical compositions and methods for their use in treating renal diseases. These compounds are particularly important as they may control the activity or the amount of heme-oxygenase, a key enzyme in various biological processes. Another significant patent involves the metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine. These metabolites act as RAGE antagonists and are useful in assays for measuring the presence or amount of metabolites within samples.
Career Highlights
Victory's career includes valuable experience with companies such as VTV Therapeutics LLC and Purdue Pharma L.P. His work has not only advanced the scientific community's understanding of pharmaceuticals but also contributed to the development of new therapeutic options for patients.
Collaborations
Throughout his career, Samuel F. Victory has collaborated with notable individuals, including Robert Carl Andrews and Adnan M. M. Mjalli. These collaborations have played a significant role in enhancing his research and patent applications, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Samuel F. Victory stands out as a dedicated inventor whose work reflects a commitment to improving healthcare through innovative drug development. His patents, specifically in the realm of substituted fused imidazole derivatives, exhibit the potential to transform treatments for renal diseases and pave the way for future research in metabolic antagonism.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile